Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interactions between von Willebrand factor and Factor VIII: where did they first meet.

× No keyword cloud information.

17 in total

1. A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

Authors: Flora Peyvandi; Giancarlo Castaman; Paolo Gresele; Raimondo De Cristofaro; Piercarla Schinco; Antonella Bertomoro; Massino Morfini; Gabriella Gamba; Giovanni Barillari; Víctor Jiménez-Yuste; Cristoph Königs; Alfonso Iorio; Augusto B Federici
Journal: Blood Transfus Date: 2019-02-04 Impact factor: 3.443

Review 2. Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors: Robert R Montgomery; Qizhen Shi
Journal: Thromb Res Date: 2012-03-14 Impact factor: 3.944

Review 3. Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, Argentina.

Authors: R R Montgomery; P E Monahan; M C Ozelo
Journal: Haemophilia Date: 2010-07 Impact factor: 4.287

Review 4. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors: Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal: Blood Date: 2016-09-01 Impact factor: 22.113

Review 5. Platelets as delivery systems for disease treatments.

Authors: Qizhen Shi; Robert R Montgomery
Journal: Adv Drug Deliv Rev Date: 2010-07-07 Impact factor: 15.470

6. Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice.

Authors: Q Shi; E L Kuether; J A Schroeder; S A Fahs; R R Montgomery
Journal: Haemophilia Date: 2012-01-04 Impact factor: 4.287

7. Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.

Authors: Qizhen Shi; Scot A Fahs; Erin L Kuether; Brian C Cooley; Hartmut Weiler; Robert R Montgomery
Journal: Blood Date: 2010-07-06 Impact factor: 22.113

8. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects.

Authors: T T Knudsen; S Thorsen; S A Jensen; K Dalhoff; L E Schmidt; U Becker; F Bendtsen
Journal: Gut Date: 2005-04 Impact factor: 23.059

9. A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.

Authors: M V Ragni; R C Jankowitz; H L Chapman; E P Merricks; M T Kloos; A M Dillow; T C Nichols
Journal: Haemophilia Date: 2008-08-01 Impact factor: 4.287

10. Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.

Authors: David A Brott; Anne Katein; Heath Thomas; Michael Lawton; Robert R Montgomery; Rudy J Richardson; Calvert S Louden
Journal: Toxicol Pathol Date: 2014-02-04 Impact factor: 1.902